Ependymoblastoma

2

Review clinical trials related to Ependymoblastoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

Pilot study to determine feasibility of adding intrathecal chemotherapy and maintenance therapy after high dose chemotherapy for treatment of newly diagnosed HR-EBTs in patients less than 6 years of age.

Participants needed: 15
Trial details
Phase: Early Phase 1Age: Up to 6Biological sex: AllType: InterventionalSponsor: C17 CouncilUpdated: Jun 8, 2026Locations: 12
Eligibility criteria

Tumor Tissue Sample [+13]

Patients who are receiving any other conventional anti-cancer agents or investig... [+7]

Status: Available

An Intermediate Expanded Use Trial of DFMO

To provide DFMO in an expanded use setting to subjects with relapsed rare tumors with increased LIN28 expression or MYCN amplification or up regulation of ornithine decarboxylase.

Trial details
Age: 0-30Biological sex: AllType: Expanded AccessSponsor: Giselle ShollerUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Age: 0-30 years at the time of initial diagnosis. [+9]

BSA (m2) of <0.25 [+1]